Methyltransferase enzymes have been associated with different processes within cells and viruses. Specifically, within viruses, methyltransferases are used to form the 5′cap-0 structure for optimal evasion of the host innate immune system. In this paper, we seek to discuss the various methyltransferases that exist within single-stranded RNA (ssRNA) viruses along with their respective inhibitors. Additionally, the importance of motifs such as the KDKE tetrad and glycine-rich motif in the catalytic activity of methyltransferases is discussed.
1
18 June 2024 in Clinical Pharmacology & Therapeutics
Protein-ligand binding affinity prediction is a fundamental task in computational drug discovery. Although substantial efforts have been made to enhance prediction accuracy using data-driven approaches, progress remains limited by persistent data scarcity. The widely used PDBbind dataset, for example, contains fewer than 20,000 experimental structures with annotated binding affinities, while a vast number of affinity measurements remain underutilized due to missing structural data. Here, we investigate this untapped potential by curating more than 450,000 synthetic protein-ligand complexes annotated with Kd and Ki values using the Boltz-1 structure prediction model. Building on this unprecedented scale of synthetic data, further augmented with over 1 million synthetic complexes from the recently released SAIR database annotated with IC50 values, we develop GatorAffinity, a geometric deep learning-based scoring function pre-trained on large-scale synthetic data and fine-tuned using high-quality experimental structures from PDBbind. Extensive evaluation on a leak-proof benchmark demonstrates that GatorAffinity significantly outperforms state-of-the-art affinity prediction methods, offering superior accuracy and generalizability. Our findings show that augmenting available experimental data with synthetic complexes can effectively address the data scarcity challenge while maintaining strong predictive reliability. By releasing the pretrained GatorAffinity model and the large-scale synthetic dataset GatorAffinity-DB, we provide a scalable and reproducible foundation for affinity prediction, virtual screening, and broader structure-based drug design applications (https://github.com/AIDD-LiLab/GatorAffinity).
9 January 2026 in ACS Pharmacology & Translational Science
Dopamine D4 receptor (D4R) signaling affects decision-making, memory formation, cognition, and attention. Previously developed D4R-selective ligands were metabolically unstable in vivo due to amide bond linker hydrolysis. In this study, analog compounds were synthesized using click chemistry, bioisosterically replacing amides with a 1,2,3-triazole linker. Herein, we report 1,2,3-triazole analogs maintained high D4R affinity and subtype selectivity but had slightly reduced functional efficacy in cAMP and β-arrestin recruitment assays. Using rat and human liver microsomes to evaluate phase I metabolism, we determined that amide ligands were more metabolically unstable in rat microsomes, and the triazole substitutions enhanced compound stability. Four compounds were evaluated in rat pharmacokinetics studies. In particular, 17 (antagonist) and 18 (low-efficacy partial agonist) had desirable results in plasma half-life and brain exposure measures. These new analogs are suitable for behavioral studies in rats and represent improved molecular tools to further explore D4R signaling in rodent models.
Dopamine D4 receptor (D4R) signaling affects decision-making, memory formation, cognition, and attention. Previously developed D4R-selective ligands were metabolically unstable in vivo due to amide bond linker hydrolysis. In this study, analog compounds were synthesized using click chemistry, bioisosterically replacing amides with a 1,2,3-triazole linker. Herein, we report 1,2,3-triazole analogs maintained high D4R affinity and subtype selectivity while retaining their functional activity. Using rat and human liver microsomes to evaluate phase I metabolism, we determined that amide ligands were more metabolically unstable in rat microsomes, and the triazole substitutions enhanced compound stability. Four compounds were evaluated in rat pharmacokinetics studies. In particular, 17 (antagonist) and 18 (low-efficacy partial agonist) had desirable results in plasma half-life and brain exposure measures. These new analogs are suitable for behavioral studies in rats and represent improved molecular tools to further explore D4R signaling in rodent models.
9 November 2026 in Journal of Chemical Theory and Computation